Crossmark

Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy

Crossref DOI link: https://doi.org/10.1186/s13052-020-0798-4

Published Online: 2020-04-03

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Manti, Sara

Parisi, Giuseppe Fabio https://orcid.org/0000-0003-4291-0195
Papale, Maria

Licari, Amelia

Salpietro, Carmelo

Miraglia del Giudice, Michele

Marseglia, Gian Luigi

Leonardi, Salvatore
License Information

Text and Data Mining valid from 2020-04-03

Version of Record valid from 2020-04-03
More Information

Article History

Received: 31 October 2019

Accepted: 9 March 2020

First Online: 3 April 2020

Ethics approval and consent to participate

: Institutional Review Board both of University of Catania and University of Messina approved the study. A written informed consent was obtained from the parents and informed assent from the children and adolescents.

: Not applicable.

: The authors have no conflicts of interest to disclose that could be perceived as prejudicing the impartiality of the research reported.

Document is current

Any future updates will be listed below